Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. JAMA. 2002 Jul 17; 288(3):311; author reply 312-3.
View in:
PubMed
subject areas
Antiparkinson Agents
Benzothiazoles
Brain
Cocaine
Dopamine Agonists
Dopamine Plasma Membrane Transport Proteins
Humans
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Parkinson Disease
Radiopharmaceuticals
Thiazoles
Tomography, Emission-Computed, Single-Photon